About
Dr. Philip Choi is an Adjunct Clinical Associate Professor at Monash University's Eastern Health Clinical School. His expertise spans stroke medicine, neurology, and clinical trials, with a focus on thrombolytic therapies and emergency stroke care. He holds a PhD in Medicine from Flinders University (2024), focusing on acute ischaemic stroke assessment.
Key projects include leading a phase 3 trial evaluating Momelotinib for myelofibrosis and a longitudinal study on secondary cerebrovascular events post-TIA. He has authored over 70 publications, with recent work focusing on tenecteplase efficacy in minor strokes, tranexamic acid in intracerebral haemorrhage, and DOAC rapid testing protocols.
- Research Interests: Stroke treatment protocols, thrombosis management, neuroimaging, clinical trial design, and post-stroke recovery.
- Recent Projects:
- TEMPO-2 trial (tenecteplase vs standard care for minor ischemic stroke)
- STOP-MSU trial (tranexamic acid in intracerebral haemorrhage)
- DOAC Dipstick consensus guidelines
- Grants & Funding: Active and completed projects supported by Pfizer and institutional funding.
His work contributes to UN Sustainable Development Goals related to health equity and neurological disorder management. Ongoing initiatives include developing stroke care platforms and optimizing rehabilitation pathways.
Find Philip Choi elsewhere
Related Searches
You Might Also Like
- LLesley CalaThe University of Western Australia · Clinical Professor
- TThalia FieldUniversity of British Columbia · Associate Professor
- XXuya HuangUniversity of Glasgow · Associate Clinical Professor
- MMartin KrauseUniversity of Sydney · Associate Clinical Professor
- OOladi S BenthoUniversity of Minnesota Twin Cities · Associate Professor
- LLouisa Marguerite ChristensenUniversity of Copenhagen · Associate Clinical Professor